A phase III, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of DE-130ª with Xalatan in patients with open-angle glaucoma or ocular hypertension over a 3-month period, followed by a 12 month period, followed by a 12-month follow-up with open-label DE-130A treatment
01/08/2023
INVESTIGADOR:
Dr. Pedro Pablo Rodríguez Calvo
FINALIZADO
A phase III, multinational, multicenter, investigator-masked, randomised, active-controlled trial, comparing the efficacy and safety of DE-130ª with Xalatan in patients with open-angle glaucoma or ocular hypertension over a 3-month period, followed by a 12 month period, followed by a 12-month follow-up with open-label DE-130A treatment